Ultimovacs to Present at Cowen Healthcare Conference
Oslo, February27, 2023: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces today that Carlos de Sousa, Chief Executive Officer and Jens Bjørheim, Chief Medical Officer, will present Ultimovacs at the Cowen Healthcare Conference on Monday, March 6 at 2:50 PM (EST). A webcast of the presentation will be available on the Company website.
Cowen’s 43rd Annual Health Care Conference is taking place March 6 - 8, 2023, at the Boston Marriott Copley Place in Boston, MA. The conference incorporates presentations, fireside chats and innovative panel discussions hosted by members of the Cowen research team that focus on various aspects of the healthcare industry.
About Ultimovacs
Ultimovacs is a clinical-stage biotechnology leader developing novel immunotherapeutic cancer vaccines to treat a broad range of cancer types. Ultimovacs’ lead universal cancer vaccine candidate, UV1, targets human telomerase (hTERT), present in 85-90% of cancers in all stages of tumor growth. By directing the immune system to hTERT antigens, UV1 drives CD4 helper T cells to the tumor to activate an immune system cascade and increase anti-tumor responses. With a broad Phase II program in five cancer indications enrolling more than 650 patients in Europe, the US and Australia, Ultimovacs aims to clinically demonstrate UV1’s impact in multiple cancer types, in combination with other immunotherapies, for patients with unmet needs. Ultimovacs’ second technology approach, the proprietary Tetanus-Epitope-Targeting (TET) platform, combines tumor-specific peptides and a tetanus-based adjuvant in the same molecule.
For further information, please see www.ultimovacs.com or contact:
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Anne Worsøe, Head of IR & Communication
Email: anne.worsoe@ultimovacs.com
Phone: +47 906 86815
Mary-Ann Chang, LifeSci Advisors
Email: mchang@lifesciadvisors.com
Phone: +44 7483 284 853
This non-regulatory stock exchange announcement was published by Anne Worsøe, Head of IRat Ultimovacs ASA, on February27, 2023 at 08:00CET.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Classic Parade announces its incorporation as an LTD company27.3.2023 16:36:04 CEST | Press release
LONDON, March 27, 2023 (GLOBE NEWSWIRE) -- After 20 years under family ownership, Classic Parade, a hypercar hire company in London, will now effective immediately become an LTD company that has financial backing from Qatari investors. This move comes from a strategic business decision to focus on growth beyond the United Kingdom. Currently, Classic Parade services luxury hypercar hire customers all over the UK, but with the revitalizing investment from its new owners, it aims to become the premium hypercar hire company that services all of Europe. No other luxury supercar for-hire provider serves that large of a geographical location in the area; Classic Parade will be the first. Its existing portfolio of vehicles is vast, including well-known brands in the luxury vehicle community such as Ferrari, McLaren, Rolls Royce, Porsche, Audi, and more. A hire agreement can be completed in as little as 24 hours, making it possible to get a next-day hypercar hire in the UK. With these same serv
Kallelse till årsstämma i Bilia AB27.3.2023 16:30:00 CEST | Pressemelding
Aktieägarna i Bilia AB, org.nr. 556112-5690, kallas till årsstämma onsdagen den 26 april 2023 klockan 14:00 på Haga Norra, Torfredsplatsen 1. Inregistrering börjar kl. 13:00. Styrelsen har beslutat att aktieägare ska kunna utöva sin rösträtt på årsstämman även genom poströstning i enlighet med föreskrifterna i Bilia AB:s bolagsordning. Förutsättningar för deltagande A. Aktieägare som önskar delta i årsstämman genom poströstning ska dels vara registrerad i den av Euroclear Sweden AB förda aktieboken avseende förhållandena den 18 april 2023,dels anmäla sig genom att avge sin poströst enligt anvisningar under rubriken Poströstning nedan så att poströsten är Computershare AB tillhanda senast den 20 april 2023. B. Aktieägare som önskar närvara i stämmolokalen personligen eller genom ombud ska dels vara registrerad i den av Euroclear Sweden AB förda aktieboken avseende förhållandena den 18 april 2023,dels anmäla sig hos bolaget senast den 20 april 2023 under adress Computershare AB, ”Bilia A
Notice of the Annual General Meeting in Bilia AB27.3.2023 16:30:00 CEST | Press release
The shareholders of Bilia AB, org.no. 556112-5690, are hereby given notice of the Annual General Meeting (“AGM”) to be held on Wednesday 26 April 2023 at 14:00 at Haga Norra, Torfredsplatsen 1, Solna. Registration for the AGM will commence at 13:00. The Board of Directors has decided that the shareholders shall be able to exercise their voting rights by postal voting in accordance with the company´s articles of association. Preconditions for participation A. Shareholders who wish to participate at the AGM by postal voting must: be recorded in the shareholders’ register kept by Euroclear Sweden AB as per 18 April 2023,and must notify its intention to participate by casting its postal vote in accordance with the instructions under the heading “Postal voting” so that the postal vote is received by the company through Computershare AB no later than 20 April 2023. B. Shareholders who wish to participate at the AGM in person or by proxy must: be recorded in the shareholders’ register kept by
Monument Commences Mining High Grade Sulphide Ore at Selinsing Gold Mine27.3.2023 16:28:27 CEST | Press release
VANCOUVER, British Columbia, March 27, 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) ("Monument" or the "Company") is pleased to update the progress at the Selinsing Sulphide Project with the commencement of mining high grade sulphide ores from Buffalo Reef at the Selinsing Gold Mine in Malaysia. New mining equipment has been mobilized to increase mining production rates to meet commercial production rates through the soon to be commissioned sulphide treatment plant which is nearing nameplate capacity in readiness for gold concentrate sales. President and CEO Cathy Zhai commented, “The mining team have been undertaking pre-stripping activities at the Buffalo Reef area since July 2022 and has now recently exposed significant areas of sulphide ores. These higher-grade fresh ore zones will provide ample feed to enable the new processing plant to reach full production capacity in the coming weeks, and will allow the revenue stream from concentrate sales to com
Management's or Related parties' trading with SP Group A/S shares27.3.2023 16:28:01 CEST | Press release
Today, Schur Finance a/s, related parties to Chairman Hans W. Schur (Hans W. Schur is Managing Director of Schur Finance a/s), has acquired 5,000 number of SPG shares, ID Code DK0061027356, at a price of DKK 240.00 equal to DKK 1,200,000.00 and Today, Chief Executive Officer, Frank Gad, has acquired 6,000 number of SPG shares, ID Code DK0061027356, at a price of DKK 238,39 equal to DKK 1,430,365,80. Attachment Meddelelse nr. 17 - Insider Trading - ENG - 27 03 23